ロード中...
Aptamers: a novel targeted theranostic platform for pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is an extremely challenging disease with a high mortality rate and a short overall survival time. The poor prognosis can be explained by aggressive tumor growth, late diagnosis, and therapy resistance. Consistent efforts have been made focusing on early tumor...
保存先:
| 出版年: | Radiat Oncol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7409417/ https://ncbi.nlm.nih.gov/pubmed/32758252 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-020-01624-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|